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Abstract
Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for differences in gene
expression between the cell lines derived from different tumour samples, and to investigate if these differences can be used
to cluster the cell lines into distinct groups. Dividing the cell lines into classes can help to improve diagnosis and the
development of screens for new drug candidates. The micro-array data is first subjected to quality control analysis and then
subsequently normalised using three alternate methods to reduce the chances of differences being artefacts resulting from
the normalisation process. The final clustering into sub-classes was carried out in a conservative manner such that sub-
classes were consistent across all three normalisation methods. If there is structure in the cell line population it was
expected that this would agree with histological classifications, but this was not found to be the case. To check the
biological consistency of the sub-classes the set of most strongly differentially expressed genes was be identified for each
pair of clusters to check if the genes that most strongly define sub-classes have biological functions consistent with NSCLC.
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Introduction
The use of cell lines in biology as a replacement for whole animal
studies plays a significant role in reducing the number of animal
experiments that have to be carried out in bio-medical research. An
important assumption is that gene expression in the cell lines reflects
the expression patterns of the tissue from which it was isolated.
Recently there has been growing criticism of the use of cell lines in
cancer research because of problems with stability, misidentification
and contamination [1,2].With newly developed cell-lines there is an
increasing need to showhow these relate to the corresponding tissues
to demonstrate that these will be an effective model for studying
cancer and developing new therapies [3].
The problems with using cell-lines for cancer research are
further exacerbated by the diversity within a supposedly single
type of cancer. Two recent studies of breast cancer have shown
that there is considerable heterogeneity in transcriptomes of
tumour cells. A study of the expression profiles from 2000 patients
with breast cancer has shown that the data can be used to first
discover and then validate subgroups [4]. In that case because of
the large number amount of data it was possible to use
independent datasets for discovery (997 cases) and validation
(995 cases). In the second smaller study 105 samples could be
divided into two robust clusters based on an analysis of a 31-gene
subset [5]. This smaller study is important because they
characterised circulating tumour cells, at the single cell level. It
is these circulating cells which have distinct expression profiles
from the breast cancer cell lines that are responsible for secondary
tumours and metastasis.
Gene expression data can provide a starting point for the
identification of biomarkers although there are considerable
challenges to finding a signal amongst noisy data. Existing
methods have used microarray data and while these methods
are giving way to next generation sequencing technologies, they
currently still provide a cheap, accessible and relatively easy to use
alternative for gene profiling at the whole organism level [6].
A survey of median survival rates for cancer by Macmillan
Cancer Support showed that whilst the median cancer survival
times had increased for many types of cancers there has been little
improvement in the last 40 years in lung cancer survival rates [7].
This is despite lung cancer being one of the most wide-spread
cancers and also the focus of considerable research. This suggests
that lung cancer may exhibit the same or an even greater degree of
diversity than breast cancer. A large amount of variability would
help to explain why progression to metastasis occurs so often and
so quickly and why existing treatments such as radio or
chemotherapy have only very limited effects.
The size of the gene expression studies available for lung cancer
is much smaller than that available for breast cancer. Lung cancers
can be divided into two major groups, Small Cell Lung
Carcinomas and Non-Small Cell Lung Carcinoma (NSCLC).
NSCLC can be further classified into three subtypes: Squamous
cell carcinoma, Adenocarcinoma, and large cell carcinoma [8].
The largest current publicly available dataset contains expression
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data for only 54 NSCLC cell lines. This data was collected by Sos
and coworkers as part of a study to show that the cell lines are
representative of tumour samples and to validate their use for drug
discovery [9].
In this paper the transcriptomic datasets from that study are
used to look for heterogeneity in gene expression that can then be
used to cluster the cell-lines. In the work of Sos and co-workers
they combined phenotype screening data to distinguish cell lines
that used the PI3K and MAPK pathways to suggest that a broad
target therapy that targets both pathways may be an effective
treatment across all NSCLC variants [10]. In this case we are
taking the opposite approach. By using the gene expression
variation we show how an appropriate screen can be designed that
will cover the full diversity of NSCLC cell lines and provide a
larger number of more specific therapeutic targets. By identifying
the key genes that are differentially expressed between the clusters,




The data consists of single arrays collected for each of the cell
lines. There are no biological or technical replicates. From a
statistical perspective the lack of replicates is a concern as without
replicates there is no measure of the variability because of either
the experimental conditions or because of biological variation.
Improvements in the production of oligonucleotide arrays have
suggested that they are now highly reproducible and that there
might no longer be a need for technical replicates except in the
case of quality control studies [11]. The downside of carrying out
more replicates is that variability can actually increase without
careful design, because of the need for more sample preparations,
more experimental runs that might be carried out over several
days and by different experimentalists. This increases the number
of variables that need to be controlled for [12]. Whether this is in
fact the case or not by using strict quality control to look for
anomalous effects the need for costly technical replication can be
avoided or at least reduced. Quality control can be either through
the design of the arrays, as in the case of adding in controls such as
house-keeping genes, or through statistical methods [13].
Turning to the problem of a lack of biological replicates, it is
very important in microarray studies to have biological replicates
in order to account for the natural variation in growth and cell
populations [14]. These variations can depend on a multitude of
factors such as variations in the growth medium, temperature and
sample handling. Unfortunately in this case there are no biological
replicates the assumption was that the gene expression data comes
cell lines that are assumed to be stable and biologically
reproducible.
A lack of biological replicates is far from ideal and without them
we do not have a reliable measure of gene expression variance at
the gene level for a single cell line. There may be biological
variation between individual cells because of the stages in their life
cycle this variation will be lost in the experimental samples which
pool expression from a population of cells. Pooling of cell line
samples has been shown to reduce the number of differentially
observed genes between treated and untreated cancer cell lines
[15]. This might also be the case here where differences in gene
expression between cell lines will be expected to be small. The
result will be fewer differentially expressed genes are observed than
actually occur and a significant number of false negatives. The
study will be less sensitive than it would have been had biological
replicates been available but for identifying subclasses this loss of
sensitivity is a less serious an issue as a large number of false
positives (Type I errors).
After clustering members of the same sub-class are assumed to
have very similar gene expression profiles and so they then provide
pseudo-biological replicates for any subsequent analysis of
differential gene expression. In this study this last step is carried
out to check for the biological consistency of the results and not in
order to identify markers for classification as the study size is too
small to allow reliable prediction of markers.
Quality Control and Normalisation
An important step in quality control of the raw array data that is
often ignored is the visual inspection of the raw array images. If
there is contamination this can either result in dark areas where
probes are obscured or bright areas where there is excessive signal.
Both of these factors will affect the results and also impair
normalisation. In this case visual inspection showed that dust
contamination was present on one of the arrays,
GSM372797.CEL (supplementary figure 1). This creates unreli-
able readings over a number of probes and so the array has to be
excluded.
In this case normalisation has to be carried out very carefully as
the comparison of differences in gene expression is made between
similar cell lines which should share very similar expression
profiles. It is important to make sure that differences are genuine
and not just the result of the normalisation process. Previous
studies have shown that normalisation can have an effect on false
discovery rate and so three normalisation methods were chosen for
normalisation in this case, based on the results of the Affycomp
study where normalisation methods are compared in samples
where data has been spiked in [16,17].
After normalisation it is important to look at the boxplots for the
distributions of expression to see if any of the arrays have outlying
expression values which will affect the results of further analysis.
These are likely to result from technical problems with some of the
probes, this was confirmed by looking at the data for spiked in
house keeping genes such as GAPDH. The unusual behaviour of
the spiked in probes indicates problems with how the sample has
been prepared and applied to the array. There is further evidence
for this conclusion as normalisation which takes into account the
probe composition (gcrma) eliminated the outlying expression
values for these arrays [18]. This shows that there is a GC/AT bias
in the sample preparation and binding. This could be a result of
the amplification process or mRNA degradation. These three
arrays (GSM372770.CEL, GSM372776.CEL and
GSM372794.CEL) were also identified as outliers in the relative
log expression for the un-normalised data and based on the
consistency of these two measures they were removed from further
study. It would be possible in studies where gcrma was the chosen
method of normalisation to have included the data but there has
been a study that has shown that gcrma has not performed as
well as other methods [16].
In this study three normalisation methods are used to reduce the
chance of normalisation affecting the probesets filtered out for
clustering and so these three arrays had to be excluded from
further analysis. All of the normalisation methods output the
expression levels on a logarithmic scale (log2) as this reduces bias
from highly expressed genes. The final boxplots for the log2
expression values of the normalised data are shown in figure 1.
Filtering
Filtering of the gene sets is necessary to deal with the statistical
challenges of dealing with so many different variables and the
curse of dimensionality [19]. Filtering has been shown to increase
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Figure 1. Boxplots of the log2 transformed data normalised using A) rma, B) gcrma, and C) farms.
doi:10.1371/journal.pone.0050253.g001
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Table 1. Values for the Filtering of the Microarray Probeset Level Data.
Target number or
probes Normalisation Method Ratio (r) Difference (d) Actual Number of Probes
300 rma 6.2 64 290
gcrma 27 64 282
farms 2.5 64 282
1000 rma 4.2 64 932
gcrma 20 64 921









Median Expression Actual Number of
Probes
300 rma 25% above 9 1.08 .9.3 308
gcrma 25% above 9 1.4 .9.3 326
farms 25% above 9 0.8 .9.3 328
1000 rma 25% above 9 0.65 .9.3 1025
gcrma 25% above 9 0.85 .9.3 1064
farms 25% above 9 0.5 .9.3 914
1B
Table 1A are the parameters for the Golub filtering and Table 1B are the parameters for the median based fitting. Where r is the ratio between the highest and lowest
level of expression for a particular probe across all the arrays and d is the difference between the maximum and minimum expression levels. IQR is the interquartile
range and the lower threshold must be passed by at least 25% of the arrays.
doi:10.1371/journal.pone.0050253.t001
Figure 2. Cluster dendrogram from hierarchical agglomerative clustering of the gcrma normalised data, filtered with interquartile
range filtering to give 282 probesets.
doi:10.1371/journal.pone.0050253.g002
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Table 2. Cluster Assignments and the Consensus From Analysis of the Dendrograms Produced by Agglomerative Hierarchical
Clustersing of the Normalised and Filtered Datasets.
Filtering Method Golub Interquartile Range
Normalisation Farms RMA GCRMA Farms RMA GCRMA
No. of Probesets L S L S L S L S L S L S
Array Consensus
GSM372745 0 2 2 2 3 3 3 3
GSM372746 0 2 2 1 2 1 1
GSM372747 0 2 1 3 3 3 3
GSM372748 2 2 2 2 2 2 2 1 1 1 1 1 1
GSM372749 2 2 2 2 2 2 2 1 1 1 1 1 1
GSM372750 0 2 2 2 2 2 2 2 2
GSM372751 0 3 2 2 2 2 2 2
GSM372752 3 3 3 3 3 3 3 2 2 2 2 2
GSM372753 2 2 2 2 2 2 2 1 3
GSM372754 1 1 3 1 3 1 3 3 3
GSM372755 1 1 1 1 1 1 1 1 1 1
GSM372756 3 1 3 3 3 3 1 3 3
GSM372757 0 2 2 2 2 2 2 2 3 3 3 3
GSM372758 0 2
GSM372759 2 2 2 2 2 2 2 2 2 2
GSM372760 0 1 3 1 1 1 3 3 3 3 3
GSM372761 1 1 1 1 1 1 1 2 2 2 2 2 2
GSM372762 3 3 3 3 3 3 3 2 2 2 2 2 2
GSM372763 1 1 1 1 1 1 1 1 1 1 1 1
GSM372764 2 2 2 2 2 2
GSM372765 3 1 1 1 3 3 3 3 3 3
GSM372766 3 3 3 3 3 3 3 3 3 3 3
GSM372767 3 3 3 3 3 3 3 1 1 1 1 1 1
GSM372768 2 2 2 2 2 2 2 1 1
GSM372769 1 1 1 1 1 1 1 3 3 3 3 3 3
GSM372771 2 2 2 2 2 2 2 1 1 1 1
GSM372772 0 2 2 2 2 2 2 2 2 2 2
GSM372773 1 1 1 1 1 1 1 2 2 2 2 2 2
GSM372774 1 1 1 1 1 1 1 1
GSM372775 1 1 1 1 1 1 1 1 1 1 1 1 1
GSM372777 1 1 1 1 1 1 1 2 2 2 2 2 2
GSM372778 0 2 2 1 3 1 1 1 1
GSM372779 0 2 1 3 3 3 3
GSM372780 1 1 1 1 1 1 1 2
GSM372781 1 1 1 1 1 1 1 1 3
GSM372782 1 1 1 1 1 1 1 1 1 1 1
GSM372783 2 2 2 2 2 2 1 1 1 1 1 1
GSM372784 2 2 2 2 2 2 2
GSM372785 0 1 2
GSM372786 1 1 1 1 1 1
GSM372787 0 2 1
GSM372788 0 2 2 2 2 2
GSM372789 1 1 1 1 1 1 1 1 1 1 1 3
GSM372790 1 1 1 1 1 1 2 2 2 2 2
GSM372791 2 2 2 2 2 2 2 1 1 1 1 1 1
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the power of subsequent statistical tests, because many fewer tests
are needed [20]. With many variables it is very easy to over-fit the
data to the model and even after filtering to 1000 and 300
probesets the data is still under-powered as there are only around
50 experimental data-points and ideally we need more data-points
than variables for an effective model where there will not be over-
fitting. Many of the genes will show negligible variation between
the different cell lines and others will be strongly correlated to one
another so that there will be redundancy in the data. Unfortu-
nately without a prior knowledge of the relationships between
genes we cannot do anything to reduce this redundancy as it is not
clear which genes are causing the effect and which are responding
to the variation in expression of this gene. In fact in a gene network
cause and effect can be particularly unclear. Ideally with more
data from more cell lines an iterative approach could be taken
where more genes are added to the model as correlated genes are
removed. In this case there is insufficient data for such a
comprehensive approach. It is therefore necessary to apply a
cut-off to select the most variable probesets for clustering. This is
somewhat arbitrary and so filtering was carried out at two different
levels to see if this affected clustering. Filtering was carried out to
produce subsets of around 1000 and 300 probesets.
Golub et al. suggested a filtering method that depends on the
ratio (r) and the difference (d) between the maximum and
minimum values for the expression of a gene across all the arrays
[21]. In this case it was expected that the cell lines should be very
similar, especially those with the same classifications and that only
a very few probesets would show any changes. The minimum
difference in expression between the maximum and minimum was
set to 64 which agrees with the array intensity distributions. This
method was applied to the data before log transformation and so
as the output of normalisation are log2 transformed measures of
expression it is necessary to transform the maximum and
minimum values back into the original scale to use this filtering
method. There is considerable variation in the values needed to
select around 1000 and 300 probes between the different
normalisation methods (see table one). It is interesting that farms
normalised data exhibits a much lower degree of variation to the
other normalisations, but that gcrma has much lower values. The
values of r and d are given in table one, along with the actual
number of filtered probesets.
A more robust measure of variability is the interquartile range,
as this is less sensitive to outliers with either higher or lower
expression values than usual. Filtering was also carried out using
this method which uses a three component filtering. The first is
that over 25% of the arrays should be above the third quartile of
the expression for the normalised arrays (it was set to 512 is
absolute terms or 9 in log2 transformed values as the 3rd quartile
for the arrays was between 8 and 9), second the interquartile range
should be about a threshold, third the median of the gene
expression should be also be about the third quartile of the
expression for the normalised arrays (in this case a cut-off of 600 in
absolute units or 9.3 in log2 transformed data). The values of the
interquartile ranges for this alternative filtering method and the
number of probesets are also given in table one.
Clustering
In the large-scale study for breast cancer where the researchers
had 2000 cases they were able to split the data into a subset for
training and a subset for validation of the clusters (subsets). In this
case there are only 50 cases after normalisation, with this data the
aim is to show that there are identifiable subsets within the data
that have a biological explanation. As NSCLC can be divided into
different sub-groups it is expected that the sub-groups should
correspond to these classifications from histology. The main
concern in clustering is making sure that clusters are not artefacts
that arise from the normalisation process, the filtering of the genes
or the clustering process itself. The simplest clustering method is
agglomerative hierarchical clustering with average cluster distanc-
es. By using this method on the data from all three normalisations
and the four different sets of gene filters we get twelve trees from
which a consensus clustering can be calculated. By looking for
clusters that are conserved in all twelve trees we can produce
conservative clusters that contain a group of core members, which
have very close gene expression profiles. These core clusters of cell
lines can then be used to investigate which differences in gene
expression distinguish the clusters. An example clustering dendro-
gram is given in figure 2 and a summary of the consensus
clustering is given in table two. All of the cluster dendrograms are
available in the supplementary material.
After consensus analysis three clusters were identified. The
largest of which contains 16 cell lines, the second largest 11 cell
lines and the smallest 7 cell lines. In total 35 out of 50 cell lines can
be clustered into these groups. Cell-lines that could not be
consistently assigned to a single group were not assigned to any
cluster. For example array GSM372762 could be in either cluster
2 or 3 and so because of this ambiguity no cluster can be firmly
assigned. By using twelve different normalisation and filtering
combinations to generate the data for clustering and only assigning
arrays that are consistently in the same cluster, this conservative
Table 2. Cont.
Filtering Method Golub Interquartile Range
Normalisation Farms RMA GCRMA Farms RMA GCRMA
No. of Probesets L S L S L S L S L S L S
GSM372792 1 1 1 1 1 1 1 1
GSM372793 2 2 2 2 2 2 2 1 1 1 1
GSM372795 3 3 3 3 3 3 3
GSM372796 1 1 1 1 2 2
GSM372798 0 1 1 1 1 1 1
The two filtering methods are that according to Golub or using the Interquartile Range [21]. The normalisation methods are farms, rma or gcrma. The probeset sizes are
approximately 1000 (L) or approximately 300 (S). The arrays are assigned to clusters 1,2,3 or 0 means there is no consensus and gaps indicate not cluster was assigned
from that dendrogram.
doi:10.1371/journal.pone.0050253.t002
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approach reduces the likelihood of discovering meaningless
clusters. Ideally the data should be divided into two groups, one
for cluster discovery and the second for cluster validation, but in
this case there is insufficient data to take this approach. Using
alternative methods to test the robustness of the clusters and their
sensitivity to changes in the normalisation and filtering is as much
as can be done with such a small dataset.
Of the remaining cell lines that could not be clustered three are
clear outliers to the rest. These are consistently at the base of the
tree in all of the alternative clusterings and so are at some distance
from the other cell lines. They are arrays GSM372758.CEL,
GSM372779.CEL, GSM372788.CEL. These three arrays are
annotated as Neuroendocrine IV, Large Cell Carcinoma, and
Unknown respectively. This result suggests that these cell lines are
single examples of distinctive expression types that are quite
distant from the main grouping of NSCLC cell lines. These lines
have been shown to be important in contributing to the gene
expression signature used to distinguish lung cancer progression
but as only single cell-lines for each type are currently available
they are atypical of the existing NSCLC data, and so they are not
ideal candidates at this time for testing novel chemical entities that
are targeted across a broad spectrum of cases [22]. In the future as
more examples become available these may form other distinct
clusters.
The three final clusters are shown in table three along with their
annotations. The largest of these contains 16 arrays. The closest of
the other subsets to this group is cluster 3, while cluster 2 is a more
distant group. Subset one correspond to adenocarcinoma as an
annotation. This is the largest annotated group of cell lines but this
has been broken down into subtypes that are not seen in the
clustering. There are also a large number of adenocarcinoma cell
lines that do not fall clearly into this group. The second subset has
a mixture of annotations but Squamous Cell Carcinoma is the
most frequent. The final cluster is too small to draw any clear
conclusions about annotations but it seems to contain a mixture of
histological categories. This suggests that while there is some
agreement between the histological classification and the expres-
sion profile clustering, the agreement is not perfect and the
expression data gives a an additional measure for classification. If
we can develop a classifier based on genetic markers this will help
to improve NSCLC classification methods.
Expression Differences Between Clusters
While it is not the aim of this study to find the differentially
expressed genes between the clusters identification of the most
significant genes responsible for each of the clusters provides
further biological support for the sub-groups.
Statistical tests can be carried out to identify the genes that are
differentially expressed between the clusters. As there are a large
number of tests that are carried out there has to be a correction for
multiple testing and the most frequently used correction is that of
Benjamini and Hochberg, as Bonferroni correction is too
conservative and would mean rejecting all genes that are
potentially differentially expressed [23]. With the reduced datasets
of around 300 genes and 1000 genes, multiple testing is not as
serious a problem as with the unfiltered dataset. Data from all
three normalisations and both filtering choices were used to carry
out the tests using limma. Figure 3 shows a heatmap of the genes
responsible for distinguishing clusters one and two after gcrma
normalisation and IQR filtering for approximately 1000 probes.
Heatmaps were generated for differentially expressed genes
between all of the clusters for all of the filtering and normalisation
methods. While some genes are found in common between
methods there is considerable variation.
The filtering method had a dramatic effect on the number of
genes identified as differentially expressed between the sub-groups.
In the case of clusters 1 and 3 filtered using the IQR method no
genes were found to be differentially expressed at a significant level
(corrected p-value of 0.01). Cluster three is a sub-group or a
branching off from the main subgroup – cluster one but it was still
expected that would be some significant level of differences in gene
expression, but this was not the case when IQR is the filtering
method. However in the case of using the Golub method for
filtering, there are a number of significantly differentially expressed
genes. This suggests that either the IQR filtering is losing some of
Table 3. The three identified clusters and their annotations.
Array Cell Line Type
Cluster One GSM372754 H1648 Adenocarcinoma IIIA
GSM372755 H1650 Adenocarcinoma IIIB
GSM372761 H1975 Adenocarcinoma
GSM372763 H2009 Adenocarcinoma IV
GSM372769 H2347 Adenocarcinoma I
GSM372773 H3122 Adenocarcinoma IV
GSM372775 H3255 Adenocarcinoma IIIB
GSM372777 H441 Papillary Adenocarcinoma
GSM372780 H820 Papillary Adenocarcinoma









Cluster Two GSM372748 Calu6 NSCLC
GSM372749 H1299 Large cell carcinoma
GSM372753 H157 Squamous cell carcinoma
GSM372759 H1792 Adenocarcinoma IV
GSM372764 H2052 Mesothelioma IV
GSM372768 H23 Adenocarcinoma
GSM372771 H2882 Squamous cell carcinoma
IV
GSM372783 HCC1359 Spindle-giant cell
carcinoma






GSM372752 H1437 Adenocarcinoma I
GSM372756 H1666 Adenocarcinoma III
GSM372762 H1993 Adenocarcinoma IIIA
GSM372765 H2087 Adenocarcinoma I
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the diversity in gene expression by being too stringent leading to
type II errors, or that the Golub filtering method is prone to type I
errors by finding signal amongst the noise. This was a consistently
identified sub-group and so some feature in the gene expression
variation must be responsible for distinguishing this cluster from its
neighbours even if this is below the threshold of statistical
significance.
Figure 3. Heatmap for the differentially expressed genes between clusters 1 and 2 for the rma normalised data filtered using the
IQR method to give 1025 probes.
doi:10.1371/journal.pone.0050253.g003
Table 4. Differentially Expressed Genes Between the Different Clusters.
Differentially Expressed Between Cluster 1 and 2 Function
SCNN1A Sodium channel and ion regulation – signal transduction
SCEL Sciellin – metal binding protein, epidermis development.
KRT19 Keratin 19– cytoskeletal protein.
RAB25 Member of the RAS oncogene family.
MAGE Family Melanoma Antigen Family.
Differentially Expressed between Cluster 1 and 3 Function
TFF1 Trefoil Factor One
CPE Carboxypeptidase E
FGG Fibrinogen Gamma Chain - Coagulation
CPS1 Carbamoyl-phosphate Synthase – amino acid metabolism
Differentially Expressed between Cluster 2 and 3 Function
TFF1 Trefoil Factor One
FGG Fibrinogen Gamma Chain - Coagulation
AQP3 Aquaporin 3– water reabsorption
CPE Carboxypeptidase E
FGB Fibrinogen Beta Chain - Coagulation
CPS1 Carbamoyl-phosphate Synthase I – amino acid metabolism
These genes are found to be differentially expressed in most of the normalisation methods and irrespective of the level of filtering.
doi:10.1371/journal.pone.0050253.t004
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Most often the 1000 gene sets gave a larger number of
statistically significant differentially expressed genes between the
clusters than the 300 gene sets. However the ordering of the
significance of the genes was different and there was poor
agreement between the gene sets identified by both the different
filtering methods using the same normalisation method as well as
between the normalisation methods (see supplementary data). A
small number of genes were conserved as differentially expressed
between the clusters in a significant number of the normalisation
and filtering variants. A selection of these conserved genes are
given in table four. Some are genes often labelled as oncogenes but
there are others that are not usually associated. A complete list of
the differentially expressed genes between the clusters for the
different normalisation methods and different filtering methods as
well as their annotations is given in the supplementary materials.
The final check on the validity of any microarray analysis is to
see if the results make biological sense. Is differential expression of
these genes between NSCLC sub-groups reasonable, and have the
genes been associated with cancer in other studies? In many cases
there is other prior evidence of a connection between the
commonly found genes responsible for distinguishing sub-groups
and other cancer studies. Of the genes in table four all but one of
them has an existing link to cancer in the literature. Trefoil factor
one deficiency has already been identified as causing increased
tumorigenicity in human breast cancer cells [24]. Fibrinogen has
been used as a factor associated with cancer mortality, but it had
been assumed that this was a direct response to factors such as
smoking by healthy cells, rather than any direct involvement in
tumour cells [25]. Two studies have shown that Aquaporins are
associated with lung cancers [26]. Carboxypeptidase E over-
expression has been associated with cancer metastasis [27]. The
Figure 4. A flowchart summarising the quality control and normalisation steps of the data analysis. The pink boxes indicate when
decisions are made to exclude arrays from the analysis because of quality control issues.
doi:10.1371/journal.pone.0050253.g004
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identification of SCEL as a potential gene involved in differential
expression is interesting as the gene has been associated with
esophagel squamous cell carcinoma, which lends further support
to cluster 2 being associated with squamous cell carcinoma [28].
Keratin 19 is already used as a biomarker for detecting circulating
lung cancer cells [29]. Finally there is also tentative evidence that
CPS1 might also be involved in cancer although its role is
currently unclear [30].
A cause for concern is the inconsistency in genes identified as
having significantly different expression levels between the three
clusters using the three different normalisation methods. These
discrepancies show that in this case normalisation plays a part in
determining which genes are identified as significantly differen-
tially expressed between clusters. This should not be true and
hampers the reliability of gene expression analysis as well as
casting doubt on genetic markers that have been identified using
these techniques. Here the differences in expression levels should
be small as the arrays are all for similar cell lines and it is possible
that this might be an artefact of the small differences being
amplified in different ways during the normalisation process, but it
does raise questions about objectivity of normalisation methods,
and suggests that the use of multiple normalisation methods might
improve the reproducibility of gene expression analysis [16].
Conclusion
This analysis has shown that there is heterogeneity in gene
expression between the NSCLC cell lines, and that this diversity
can be used to divide the cell lines into different groups that do not
completely agree with the histological annotations. Lung cancer
was chosen for this study because of the potential variability in its
genetic make-up, which may be responsible for its rapid
progression and the difficulty in developing a successful treatment.
The variability between sub-classes suggests that it might not be
possible to develop a broad ranging treatment, but this also
presents an opportunity to develop more specific treatments and
for improved molecular diagnostics. By screening new chemical
entities against cell-lines chosen from all three sub-classes we can
hope to generate a broad specificity drug, or alternatively the focus
can be moved to targeting patients who fall into one of the subsets
for a more specific treatment.
This paper has only used a small of samples where gene
expression profiles were available and so it can only provide initial
evidence for the existence of at least three sub-groups of NSCLC,
although it is likely that with larger datasets more subgroups will
be discovered. Considerable effort is required to confirm, and
develop these findings in order to advance our understanding of
NSCLC, to the same level as breast cancer. As larger studies
containing more cell lines and gene expression data from biopsy or
single cell samples become available this diversity is likely to
increase further. With more biological replicates it will also be
possible to identify biological markers for the sub-classes and
classification methods in a robust manner. Questions have been
raised about the influence of normalisation on the results of gene
expression analysis but these could also be addressed by improved
experimental designs that include more biological replicates and
improvements in normalisation methods.
Materials and Methods
Raw data was downloaded from ArrayExpress with accession
‘EGEOD-14925’ [31]. Quality assessment was carried out using
package arrayQualityMetrics within Bioconductor to assess
the quality of 54 CEL files included in this study [32,33]. Two runs
of quality control were carried out: before and after pre-
processing. Spatial artefacts were checked for visually and array
GSM372797 was found to contain contamination from dust.
Therefore this array was excluded from further analysis.
Normalisation methods for Affymetrics arrays have been tested
as part of Affycomp where spiked in controls are used to evaluate
performance [17]. Three of the best normalisation methods are
rma, gcrma and farms [18,34]. The remaining arrays were
normalised using the three methods within Bioconductor [32].
The resulting normalised data was again subjected to quality
control analysis to look for arrays that had expression outliers in
the boxplots. This showed that there were problems with three
more arrays which were excluded from the rest of the study. These
were arrays GSM372770, GSM372776 and GSM372794. After
these arrays had been removed the data was again renormalized
using the three methods. The procedure for quality control and
normalisation is summarised in the flowchart in figure 4. Data
from quality control metrics is combined with other measures at
the decision points (shown as boxes in pink) to identify arrays
where quality control indicates there are problems. These arrays
are then excluded from subsequent analysis.
The data were then filtered to obtain datasets containing
around 1000 and 300 genes which can then be used for cluster
analysis and to determine differential gene expression. The cut-offs
for filtering were different for the three normalisation methods as
the normalised data has a different scale and spread from the
different normalisation methods. This is why filtering cut-offs
select around a target number of genes rather than an exact
number. The values used for filtering using either the method from
Golub et al. which uses differences between the maximum and
minimum expression level of a gene as well as a second filtering
method based on the interquartile range are given in table one.
Filtering was carried out using the genefilter module within
Bioconductor [35].
Clustering was carried out using agglomerative hierarchical
clustering for both the 1000 gene and 300 gene datasets. This is
perhaps the simplest possible method of clustering. There was a
good degree of consistency in the clustering between the three
different normalisation methods and the different filtering
strategies. One cluster was particularly clearly identified in all
cases. This resulted in the identification of 3 main subgroups
within the arrays, that were found consistently across all three
normalisation methods and the filtered datasets. Arrays that were
consistently found in the same cluster regardless of normalisation
method make up the core of the cluster. This resulted in 3
conservative groupings containing at least six members and
containing 34 out of total of 50 arrays. These clusters were then
used for differential gene expression analysis using limma within
Bioconductor to carry out multiple testing [36]. Benjamini and
Hochberg’s method was used to assign a corrected p-value of 0.01
[23].
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Figure S1 An image of the raw Affymetrix array
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multiple probes.
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